To Name :
To Email :
From Name :
From Email :
Comments :

Surgical Technique

Preventing VTE: Evidence-based perioperative tactics

The perfect strategy has yet to be devised, but good data point to drug and mechanical methods that come close

April 2006 · Vol. 18, No. 4
This week's quiz:
More »

Pulmonary embolism is a master of disguises. It can appear with classic symptoms such as pleuritic chest pain, hemoptysis, and tachycardia—or it can arrive more insidiously, apparent only as a slight elevation in the respiratory rate.

This matters because 40% of all deaths following gynecologic surgery are directly attributable to pulmonary emboli,1 and pulmonary emboli are the most frequent cause of postoperative death in women with uterine or cervical carcinoma.2

Deep venous thrombosis (DVT) is almost as evasive. We know the signs and symptoms of DVT of the lower extremities—pain, edema, erythema, and a prominent vascular pattern of the superficial veins—but 50% to 80% of patients with these symptoms do not have DVT, and 80% of patients with symptomatic pulmonary embolism have no antecedent signs of thrombosis in the lower extremities.2 Morbidity and expense rise dramatically with DVT, especially when postphlebitic syndrome occurs.

How can we minimize these risks?

A good outcome is most likely when we:

  • recognize risk factors,
  • provide appropriate perioperative prophylaxis, and
  • diagnose and treat venous thromboembolism (VTE) quickly.

This article looks in detail at each of these strategies.

3 factors set the stage for thrombogenesis

  • Hypercoagulable state
  • Venous stasis
  • Vessel endothelial injury

These factors, known as Virchow’s triad, are especially likely at the time of major surgery, or when the patient is advanced in age or has a history of DVT, cancer, lower extremity edema, or venous stasis.

Intraoperative risk factors for postoperative DVT include increased anesthesia time, greater blood loss, and need for transfusion.

Some preventive methods come close to ideal

Being aware of risk factors is vital to provide the appropriate level of prophylaxis (TABLES 1 AND 2).3,4 The first step is identifying high-risk patients and tailoring the regimen to meet their individual needs. The perfect prophylactic method is not yet devised, but would be effective, free of significant side effects, well accepted by the patient and nursing staff, widely applicable to most patient groups, and inexpensive. A number of methods come close.


Risk factors for thromboembolism

Major gynecologic surgery

Age >40 years


Previous venous thrombosis (DVT or pulmonary embolism)



Pregnancy and the postpartum period

Oral contraceptives, hormone therapy, or tamoxifen

Varicose veins

Inherited or acquired thrombophilia (eg, Factor V Leiden)

Prolonged surgical procedure

Radical vulvectomy, inguinal-femoral lymphadenectomy, or pelvic exenteration


Match the preventive strategy to the surgery




Procedures <30 min for benign disease

Prophylaxis not needed

Laparoscopic gynecologic procedures in women with additional risk factors

Unfractionated heparin, 5,000 bid or

Until hospital discharge

LMWH, ≤3,400 U/day or

External pneumatic compression or

Graduated compression stockings

Major surgery for benign disease without additional risk factors

Unfractionated heparin, 5,000 U bid or

Until hospital discharge

LMWH, <3,400 U/day or

External pneumatic compression

Extensive major surgery in women with cancer or additional risk factors

Unfractionated heparin, 5,000 U tid or

Until hospital discharge

LMWH, >3,400 U/day or

External pneumatic compression

*For women at particularly high risk (eg, cancer surgery, age >60 years, prior VTE), continue prophylaxis for 2–4 weeks after hospital discharge.

Modified from Geerts WH, et al20

Low-dose unfractionated heparin

The most extensively studied prophylactic method is the use of small, subcutaneous doses of heparin. More than 25 controlled trials have shown that, when heparin is given subcutaneously 2 hours before surgery and every 8 to 12 hours afterward, the incidence of DVT diminishes substantially.

The value of low-dose heparin in preventing pulmonary emboli was established by a randomized, controlled, multicenter, international trial, in which fatal postoperative pulmonary emboli declined significantly in general surgery patients given the drug every 8 hours after surgery.5 In gynecologic surgical patients, postoperative DVT also declined significantly.

Increase in minor bleeding complications. Although low-dose heparin is thought to have no measurable effect on coagulation, most large series have noted an increase in minor bleeding complications such as wound hematoma. Up to 10% to 15% of otherwise healthy patients develop transiently prolonged activated partial thromboplastin time (APTT) after 5,000 U of heparin are given subcutaneously.6

Although relatively rare, thrombocytopenia is associated with the use of low-dose heparin. It has been found in 6% of women after gynecologic surgery.6 Therefore, it is reasonable to measure platelets in any patient taking low-dose heparin longer than 4 days to screen for heparin-induced thrombocytopenia.

Fear of major bleeding complications is unsubstantiated. There is ample evidence from placebo-controlled, blinded trials and meta-analysis that the risk of clinically important bleeding does not increase. Moreover, detailed analysis demonstrates that low-dose heparin has a good risk-to-benefit ratio and is cost-effective.

Low-molecular-weight heparins

These drugs are fragments of unfractionated heparin that vary in size from 4,500 to 6,500 daltons. Low-molecular-weight heparin (LMWH) has more anti-Xa and less antithrombin activity than unfractionated heparin and thus has less of an effect on partial thromboplastin time. LMWH may also lead to fewer bleeding complications.7

Once-daily dosing is possible. An increased half-life of 4 hours for LMWH produces greater bioavailability than with low-dose heparin. This allows once-daily dosing.

Pick one: Convenience or cost

Randomized controlled trials have compared LMWH to unfractionated heparin in gynecologic surgical patients. In all studies, DVT occurred in similar, low numbers of women regardless of the heparin used. Bleeding complications also were similar.8

A meta-analysis of general surgery and gynecologic surgery patients from 32 trials likewise found daily LMWH to be as effective as unfractionated heparin in DVT prophylaxis, without any difference in hemorrhagic complications.9

The choice of drugs often boils down to convenience versus cost: Prophylactic LMWH can be given once a day (compared with 2 or 3 times for unfractionated heparin), but is much more expensive.

Mechanical prophylactic methods

External pneumatic compression rivals low-dose heparin. The largest body of literature on mechanical methods to reduce postoperative venous stasis involves intermittent leg compression by pneumatically inflated sleeves placed around the calf or leg during surgery and after. A number of devices and sleeve designs are available, none of which has proven to be superior to the others.

In my experience, calf compression during and after gynecologic surgery lowers the incidence of DVT to a level seen with low-dose heparin. Besides increasing venous flow and pulsatile emptying of the calf veins, pneumatic compression appears to augment endogenous fibrinolysis, which may stimulate lysis of very early thrombi.10

How long is best for external compression? The optimal duration of postoperative external pneumatic compression is unclear. It may be effective when used in the operating room and for the first 24 hours postoperatively in patients with benign conditions who will ambulate on the first day after surgery.11,12

In women undergoing major surgery for gynecologic malignancy, it reduces the incidence of postoperative venous thromboemboli by nearly 3-fold, but only if calf compression is applied intraoperatively and for the first 5 postoperative days.13,14 These women may remain at risk because of stasis and a hypercoagulable state for a longer time than general surgical patients.

External pneumatic leg compression has no serious side effects or risks and is slightly more cost-effective than prophylactic drugs.15 However, to be fully effective, this method must be used consistently, in compliance with the protocol, when the patient is not ambulating.

Stockings can be a help or hazard. Controlled studies of graduated pressure stockings are limited but suggest modest benefit with careful fitting.16 Poorly fitted stockings that roll down the leg may create a tourniquet effect at the knee or mid-thigh. Another disadvantage of the stockings: The limited sizes available do not allow a perfect fit for all patients. This is especially true in obese patients.

The simplicity of elastic stockings and the absence of serious side effects are probably why stockings are often included in routine postoperative care.

Don’t overlook basic precautions. Although they may offer only modest benefit, short preoperative hospital stays and early postoperative ambulation are recommended.

Another basic strategy: elevating the foot of the bed to raise the calf above heart level. This allows gravity to drain the calf veins and should further reduce stasis.

How to detect VTE

DVT has nonspecific signs and symptoms

When DVT occurs in the lower extremities, harbingers such as pain, edema, and erythema are relatively nonspecific; 50% to 80% of patients exhibiting them do not have DVT. Conversely, approximately 80% of patients with symptomatic pulmonary emboli have no signs or symptoms of thrombosis in the lower extremities.

Because of this lack of specificity, additional tests are needed to establish DVT.

Diagnostic studies

A definitive diagnosis of DVT and pulmonary embolism is mandatory because diagnosis based on clinical symptoms and signs alone is frequently wrong. Strategies to reduce the use of ultrasound or spiral CT scanning have been put forward. These studies have evaluated outpatients using algorithms that utilize clinical probability (“clinical decision rule”) and D-dimer levels.

This strategy has been very accurate and avoids the use of ultrasound or spiral CT in low-risk patients. For example, individuals with a low probability score have an incidence of DVT below 5%, so ultrasound is unnecessary. This diagnostic strategy relies on the recognition of elevated D-dimer levels. Unfortunately, D-dimer is increased by a variety of nonthrombotic disorders, including recent surgery, hemorrhage, trauma, pregnancy, and cancer. Therefore, we cannot recommend the use of this strategy for the postoperative gynecologic surgery patient.17,18

Venography no longer the gold standard. Other diagnostic studies may be more useful. Venography has fallen from favor because it is moderately uncomfortable, requires injection of a contrast material that may trigger an allergic reaction or renal injury, and causes phlebitis in approximately 5% of patients.2 Newer, noninvasive diagnostic tests have been developed, fortunately.

Doppler ultrasound. B-mode duplex Doppler imaging is the most common technique to diagnose symptomatic venous thrombosis, especially when it arises in the proximal lower extremity. With duplex Doppler imaging, the femoral vein can be visualized, and clots may be seen directly. Compression of the vein with the tip of the ultrasound probe makes it possible to assess venous collapsibility, which is diminished when a thrombus is present.

Doppler imaging is less accurate when evaluating the calf and pelvic veins.

Magnetic resonance venography (MRV) sensitivity and specificity are comparable to venography. In addition, MRV may detect thrombi in pelvic veins that are not imaged by venography. The primary drawback is the time required to examine the lower extremity and pelvis. Further, MRV rarely identifies calf thrombi (most often not life-threatening, but potentially symptomatic) and is considerably more expensive than ultrasound.


Which prevention strategy works best?

We now consider low-molecular-weight heparin and external pneumatic compression the best choices

Because low-dose unfractionated heparin, low-molecular-weight heparin (LMWH), and external pneumatic compression all reduce the incidence of postoperative venous thromboembolism in high-risk gynecologic surgical patients, the question is: Which strategy is best?

We conducted 2 randomized clinical trials to answer this question.

Trial 1 Low-dose heparin vs pneumatic compression

Women were randomized to receive either low-dose heparin (5,000 U subcutaneously preoperatively and every 8 hours after surgery until hospital discharge) or external pneumatic compression of the calf prior to surgery and until hospital discharge.1

The incidence of DVT was identical in both groups, and no patients developed a pulmonary embolus throughout 30 days of follow-up. However, bleeding complications occurred more often in the group randomized to low-dose heparin. Specifically, nearly 25% had APTT levels in the “therapeutic” range, and significantly more patients required blood transfusions. After this trial, our institution decided to use external pneumatic compression because of its more favorable risk profile.1

Did you miss this content?
Does episiotomy at vacuum delivery increase maternal morbidity?